• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声增强单纯疱疹病毒溶瘤治疗头颈部肿瘤的研究进展。

Ultrasound as a method to enhance antitumor ability of oncolytic herpes simplex virus for head and neck cancer.

机构信息

Department of Oral and Maxillofacial Surgery II, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.

Department of Dental and Oral Surgery, Izumisano Municipal Hospital, Izumisano, Osaka, Japan.

出版信息

Cancer Gene Ther. 2015 Apr;22(3):163-8. doi: 10.1038/cgt.2015.3. Epub 2015 Feb 6.

DOI:10.1038/cgt.2015.3
PMID:25656776
Abstract

Low-intensity ultrasound is a useful method to enhance the delivery of drugs to target cells via a range of mechanisms including the transient formation of micropores in the cell membrane, a process known as sonoporation. The effect of ultrasound on oncolytic herpes simplex virus type-1 (HSV-1) infection in oral squamous cell carcinoma (SCC) was examined. Human SCC cell line SAS and oncolytic HSV-1 RH2, which was deficient in the neurovirulent γ134.5 gene and exhibited cell fusion actions, were used. Cells grown in multi-well plates were infected with HSV-1 and exposed to ultrasound in the presence or absence of microbubbles after an adsorption period. The number of plaques was significantly greater than that of the untreated control. SAS cells were inoculated subcutaneously into nude mice and tumors were produced. Tumors were injected with HSV-1 RH2 with or without microbubbles and then exposed to ultrasound through the covering skin. The amount of the virus in tumor tissues 3 days after the injection was higher in tumors treated with HSV-1 RH2 and ultrasound than in tumors treated with RH2 only. The expression of the HSV-1 antigen was also increased by ultrasound and microbubbles. Tumor growth was suppressed with HSV-1 RH2 in combination with ultrasound, especially with microbubbles. These results indicated that ultrasound increased the efficiency of the HSV-1 infection in SAS cells and nude mouse tumors. This method can potentially be useful to enhance the antitumor effects of oncolytic HSV-1 on head and neck cancer treatment.

摘要

低强度超声是一种通过多种机制增强药物递送至靶细胞的有效方法,包括细胞膜中微孔的瞬时形成,该过程称为声孔作用。本研究探讨了超声对口腔鳞状细胞癌(SCC)中溶瘤单纯疱疹病毒 1 型(HSV-1)感染的影响。使用人 SCC 细胞系 SAS 和缺乏神经毒性 γ134.5 基因并具有细胞融合作用的溶瘤 HSV-1 RH2。在吸附期后,将在多孔板中生长的细胞用 HSV-1 感染,并在存在或不存在微泡的情况下进行超声处理。与未处理的对照组相比,噬菌斑的数量明显更多。将 SAS 细胞皮下接种到裸鼠中以产生肿瘤。用 HSV-1 RH2 处理肿瘤,无论是否有微泡,然后通过覆盖的皮肤进行超声处理。与单独用 RH2 处理的肿瘤相比,注射后 3 天肿瘤组织中的病毒量在接受 HSV-1 RH2 和超声处理的肿瘤中更高。超声和微泡还增加了 HSV-1 抗原的表达。与单独用 HSV-1 RH2 处理相比,联合使用 HSV-1 RH2 和超声,特别是联合使用微泡,可抑制肿瘤生长。这些结果表明,超声可提高 HSV-1 在 SAS 细胞和裸鼠肿瘤中的感染效率。该方法可能有助于增强溶瘤单纯疱疹病毒 1 对头颈部癌症治疗的抗肿瘤作用。

相似文献

1
Ultrasound as a method to enhance antitumor ability of oncolytic herpes simplex virus for head and neck cancer.超声增强单纯疱疹病毒溶瘤治疗头颈部肿瘤的研究进展。
Cancer Gene Ther. 2015 Apr;22(3):163-8. doi: 10.1038/cgt.2015.3. Epub 2015 Feb 6.
2
Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound.超声介导溶瘤性单纯疱疹病毒进入人鳞状细胞癌细胞
Viruses. 2015 Oct 26;7(10):5610-8. doi: 10.3390/v7102890.
3
Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus.溶瘤单纯疱疹病毒增强鳞状细胞癌细胞的系统肿瘤免疫
Cancer Gene Ther. 2013 Sep;20(9):493-8. doi: 10.1038/cgt.2013.45. Epub 2013 Jul 26.
4
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma.一种新型融合性单纯疱疹病毒,用于鳞状细胞癌的溶瘤病毒治疗。
Virol J. 2011 Jun 10;8:294. doi: 10.1186/1743-422X-8-294.
5
Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide.六亚甲基双乙酰胺增强单纯疱疹病毒γ(1)34.5缺陷型突变体对口腔鳞状细胞癌细胞的抗肿瘤活性
Cancer Gene Ther. 2006 Aug;13(8):780-91. doi: 10.1038/sj.cgt.7700957. Epub 2006 Apr 28.
6
Effect of ultrasound on herpes simplex virus infection in cell culture.超声对细胞培养中单纯疱疹病毒感染的影响。
Virol J. 2011 Sep 22;8:446. doi: 10.1186/1743-422X-8-446.
7
Combined oncolytic virotherapy with herpes simplex virus for oral squamous cell carcinoma.单纯疱疹病毒联合溶瘤病毒疗法治疗口腔鳞状细胞癌
Anticancer Res. 2008 Nov-Dec;28(6A):3637-45.
8
Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells.1型单纯疱疹病毒溶瘤诱导鳞状细胞癌细胞发生免疫原性细胞死亡
Cancer Gene Ther. 2016 Apr;23(4):107-13. doi: 10.1038/cgt.2016.8. Epub 2016 Mar 18.
9
Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.新型紫杉醇 2'-乙酯前药联合 HSV 扩增子与减毒复制型病毒 HF10(作为辅助病毒)联合系统增强细胞毒性。
Cancer Lett. 2010 Feb 1;288(1):17-27. doi: 10.1016/j.canlet.2009.06.014. Epub 2009 Jul 14.
10
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.溶瘤单纯疱疹病毒诱导的血小板反应蛋白表达降低所引起的血管生成反应,可通过特定的病毒突变或给予血小板反应蛋白衍生肽来预防。
Cancer Res. 2007 Jan 15;67(2):440-4. doi: 10.1158/0008-5472.CAN-06-3145.

引用本文的文献

1
The investigation of oncolytic viruses in the field of cancer therapy.溶瘤病毒在癌症治疗领域的研究。
Front Oncol. 2024 Jul 10;14:1423143. doi: 10.3389/fonc.2024.1423143. eCollection 2024.
2
Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer.高效递送和复制溶瘤病毒以成功治疗头颈部癌症。
Int J Mol Sci. 2020 Sep 25;21(19):7073. doi: 10.3390/ijms21197073.
3
Controlled Drug Delivery Systems for Oral Cancer Treatment-Current Status and Future Perspectives.用于口腔癌治疗的可控药物递送系统——现状与未来展望

本文引用的文献

1
Non-invasive and real-time passive acoustic mapping of ultrasound-mediated drug delivery.超声介导药物递送的非侵入性实时被动声学图谱
Phys Med Biol. 2014 Sep 7;59(17):4861-77. doi: 10.1088/0031-9155/59/17/4861. Epub 2014 Aug 7.
2
Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.利用聚合物隐形和聚焦超声增强病毒治疗的肿瘤摄取和穿透。
J Natl Cancer Inst. 2013 Nov 20;105(22):1701-10. doi: 10.1093/jnci/djt305. Epub 2013 Oct 29.
3
Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.
Pharmaceutics. 2019 Jun 30;11(7):302. doi: 10.3390/pharmaceutics11070302.
4
Oncolytic viruses: overcoming translational challenges.溶瘤病毒:克服转化挑战。
J Clin Invest. 2019 Mar 4;129(4):1407-1418. doi: 10.1172/JCI122287.
5
In vivo study of enhanced chemotherapy combined with ultrasound image-guided focused ultrasound (USgFUS) treatment for pancreatic cancer in a xenograft mouse model.体内研究增强化疗联合超声图像引导聚焦超声(USgFUS)治疗异种移植小鼠模型胰腺癌。
Eur Radiol. 2018 Sep;28(9):3710-3718. doi: 10.1007/s00330-018-5355-9. Epub 2018 Mar 29.
6
Ultrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of art.超声介导的溶瘤病毒递送与摄取以提高治疗效果:现状
Oncolytic Virother. 2015 Nov 25;4:193-205. doi: 10.2147/OV.S66097. eCollection 2015.
7
Oncolytic virotherapy for head and neck cancer: current research and future developments.头颈部癌的溶瘤病毒疗法:当前研究与未来发展
Oncolytic Virother. 2015 Jul 20;4:83-93. doi: 10.2147/OV.S54503. eCollection 2015.
8
Nucleic acid targeting: towards personalized therapy for head and neck cancer.核酸靶向:迈向头颈癌个性化治疗
Oncogene. 2016 Jun 23;35(25):3217-26. doi: 10.1038/onc.2015.424. Epub 2015 Nov 23.
9
Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound.超声介导溶瘤性单纯疱疹病毒进入人鳞状细胞癌细胞
Viruses. 2015 Oct 26;7(10):5610-8. doi: 10.3390/v7102890.
利用聚焦超声实现空化增强递送复制型溶瘤腺病毒至肿瘤。
J Control Release. 2013 Jul 10;169(1-2):40-7. doi: 10.1016/j.jconrel.2013.03.017. Epub 2013 Apr 4.
4
Sequence of a fusogenic herpes simplex virus, RH2, for oncolytic virotherapy.序列的融合单纯疱疹病毒, RH2 ,为肿瘤溶瘤病毒治疗。
J Gen Virol. 2013 Apr;94(Pt 4):726-737. doi: 10.1099/vir.0.044834-0. Epub 2012 Dec 12.
5
Ultrasound-enhanced drug delivery for cancer.超声增强药物递送治疗癌症。
Expert Opin Drug Deliv. 2012 Dec;9(12):1525-38. doi: 10.1517/17425247.2012.739603. Epub 2012 Nov 4.
6
In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles.超声和微泡介导的眼睫状肌内活体基因转移。
Ultrasound Med Biol. 2011 Nov;37(11):1814-27. doi: 10.1016/j.ultrasmedbio.2011.07.010. Epub 2011 Oct 2.
7
Effect of ultrasound on herpes simplex virus infection in cell culture.超声对细胞培养中单纯疱疹病毒感染的影响。
Virol J. 2011 Sep 22;8:446. doi: 10.1186/1743-422X-8-446.
8
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma.一种新型融合性单纯疱疹病毒,用于鳞状细胞癌的溶瘤病毒治疗。
Virol J. 2011 Jun 10;8:294. doi: 10.1186/1743-422X-8-294.
9
Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.一项关于单纯疱疹病毒 GM-CSF 联合放化疗治疗未经治疗的 III/IV 期头颈部鳞癌的 I/II 期临床研究。
Clin Cancer Res. 2010 Aug 1;16(15):4005-15. doi: 10.1158/1078-0432.CCR-10-0196.
10
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.鉴定 ENT1 拮抗剂双嘧达莫和地拉卓为溶瘤单纯疱疹病毒-1 复制的增强剂。
Cancer Res. 2010 May 15;70(10):3890-5. doi: 10.1158/0008-5472.CAN-10-0155. Epub 2010 Apr 27.